THIS IS not a column about whether the National Institutes of Health should continue to fund stem cell research. Having said that, my own view is that stem cells are neither less nor more important as tools for curing or treating diseases than other technologies. More to the point, genomics offers many more ways to detect and prevent disease than does stem cell technology (and indeed, without genomics, the mutations and glitches all manner of stem cells encounter en route to becoming differentiated may never be overcome).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.